Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

51.84
Delayed Data
As of Nov 22
 +0.09 / +0.17%
Today’s Change
30.89
Today|||52-Week Range
51.99
+44.56%
Year-to-Date

Today’s Trading

Previous close51.75
Today’s open51.83
Day’s range51.59 - 51.99
Volume888,980
Average volume (3 months)1,920,993
Market cap$102.0B
Dividend yield2.21%
Data as of 4:02pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.56%
Revenue growth (last year)+3.81%
P/E ratio21.1
Price/Sales5.48
Price/Book20.22

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.32-0.57%
LLYEli Lilly and Co+0.17+0.20%
BMYBristol-Myers Squibb-0.10-0.16%
GSKGlaxoSmithKline+0.25+0.72%
Data as of 4:02pm ET, 11/22/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.56
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts